CELG
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F2528754&ei=knKaUvD6OuTX0QGcJA&usg=AFQjCNHbz3uvEvOQSz1JQymONsKtamx95Q
Celgene Corporation Reaffirms FY 2012 Guidance
Thursday, 26 Apr 2012 07:01am EDT
Celgene Corporation reaffirmed fiscal 2012 guidance and expects Non-GAAP total revenue to increase approximately 15% year-over-year to a range of $5.400 to $5.600 billion. Non-GAAP diluted earnings per share (EPS) is expected to increase approximately 25% year-over-year to a range of $4.70 to $4.80. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $5.53 billion for fiscal 2012.Â 
